Table 2.
Patient characteristics at admission
| Characteristics | Group 1 2019 (137 Pts) n (%) |
Group 2 2020 (109 Pts) n (%) |
p-value |
|---|---|---|---|
| Age years, median (q1–q3) | 53 (33–70) | 48 (32–70) | 0.41 |
| Gender, n (%) | |||
| Female | 42 (30.7) | 40 (36.7) | 0.32 |
| Male | 95 (69.3) | 69 (63.3) | |
| NRS median (q1–q3) | |||
| ≤3, n (%) | 50 (37.3) | 40 (36.7) | 0.98 |
| 4–6, n (%) | 34 (25.4) | 29 (26.6) | |
| ≥7, n (%) | 50 (37.3) | 40 (36.7) | |
| NEWS at admission, median (q1-q3) | |||
| 0–4, n (%) | 101 (80.8) | 86 (78.90) | 0.39 |
| 5–6, n (%) | 10 (8.0) | 14 (12.8) | |
| ≥7, n (%) | 14 (11.2) | 9 (8.3) | |
| CCI, median (q1-q3) | 2 (0–5) | 1 (0–5) | 0.99 |
| Declared delayed access > 48 h, n (%) | 0 (0.0) | 16 (15.5) | < 0.01 |
| Sepsis criteria, n (%) | 42 (31.3) | 31 (28.7) | 0.66 |
| ASA score, median (q1-q3) | 2 (1–3) | 2 (1–3) | 0.35 |
| COVID-19 molecular swab test results, n (%) | |||
| Negative | n.a. | 81 (74.3) | |
| Positive | n.a. | 5 (4.6) | |
| Not available | n.a. | 23 (21.1) |
q1 first quartile, q3 third quartile, SD standard deviation